Roberts Glore & CO Inc Astrazeneca PLC Transaction History
Roberts Glore & CO Inc
- $328 Million
- Q4 2024
A detailed history of Roberts Glore & CO Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Roberts Glore & CO Inc holds 5,149 shares of AZN stock, worth $385,145. This represents 0.1% of its overall portfolio holdings.
Number of Shares
5,149
Previous 4,646
10.83%
Holding current value
$385,145
Previous $362,000
6.91%
% of portfolio
0.1%
Previous 0.11%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,353Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.51 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.07 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.81 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.77 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.8 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $232B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...